Limited Use Note(s)

Government of Ontario Logo
TIMOLOL MALEATE & TRAVOPROST0.5% & 0.004% Oph Sol-5mL Pk
Reason For Use CodeClinical Criteria
310As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents.
LU Authorization Period: Indefinite.
393For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.
LU Authorization Period: Indefinite.